-
Participants Dosed on Adessia in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa
PharmaSources
March 07, 2023
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and
overseas.
-
IGIS Asia Investment Management Partners with CHA Bio Group to Launch Life Science Real Estate Platform JV
PharmaSources
February 16, 2023
IGIS Asia Investment Management announced this month a partnership with CHA Bio Group, to form a new Asia-Pacific life science real estate investment platform.
-
Ajinomoto Bio-Pharma Services Names Tony O’Neill as VP of Compliance, U.S. Operations
contractpharma
January 25, 2022
O’Neill joins the company after 25 years at Allergan.
-
Element Expands Life Sciences Testing Business
contractpharma
January 24, 2022
Adds pharmaceutical and biotech testing capabilities in North America and Europe.
-
Roquette Invests $25M in U.S. Pharmaceutical Innovation Center
contractpharma
December 08, 2021
New 23,000 sq.-ft. facility will house an Applied Sciences facility for the research of excipients for oral dosage forms, drug delivery systems, and APIs.
-
FourKites, Accenture Share Global Pharma Supply Chain Insights
contractpharma
December 08, 2021
Pharma executives cite supply chain visibility as critical solution to alleviating product loss and security concerns.
-
How pharma companies can avoid cyber threats
expresspharma
December 08, 2021
Jagdish Mahapatra, VP, Asia, CrowdStrike, explains the need for pharmaceutical businesses to be equipped with the tools, education and intelligence to prevent, predict and avoid future cyber threats.
-
Roche completed the repurchase of Roche shares from Novartis
WorldPharmaNews
December 07, 2021
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it completed the repurchase of Roche shares that had been held by Novartis. On 4 November 2021, Roche and Novartis had announced this repurchase. The Extraordinary General Meeting of Roche Holding...
-
Pharma industry reports 53 deals worth $9.6 billion in November 2021: GlobalData
expresspharma
December 06, 2021
The industry reported 105 venture capital (VC) deals worth $4.2 billion in November 2021, compared to the last 12-month average (November 2020 to October 2021) of 173 deals worth $5.2 billion.
-
10th Indian Pharma Expo to be held from 10-11 December in Delhi
expresspharma
December 03, 2021
IPE offers opportunities for the participating companies to meet, showcase and promote their products and services to visitors from the pharma and healthcare industry, coming from various parts of India and around the world